BACKGROUND: We recently reported marked hyporeactivity of the hypothalamo-pituitary-adrenal (HPA) axis in depressed women on job-stress-related long-term sick leave (LTSL). This unexpected finding prompted the question of whether HPA axis hypofunction in this group results from stress exposure or reflects preexisting vulnerability. Here, as a first step toward addressing this question, we assessed temporal stability of HPA axis reactivity in these subjects. METHOD: We used the combined dexamethasone/corticotropin-releasing hormone (DEX-CRH) test to retest HPA axis reactivity in 29 patients and 27 control subjects after 12 months of follow-up. Clinical status and cognitive performance was also retested. RESULTS: Despite marked clinical improvement and normalization of initially observed impairments in attention and working memory, marked HPA axis hyporeactivity persisted in patients. A high test-retest correlation was found both at the level of corticotropin (R = .85, p < .001) and cortisol (R = .76, p < .001) responses. CONCLUSIONS: Hyporeactivity of the HPA was stable over 12 months in LTSL subjects, independent of clinical improvement and normalized cognitive function. The stability of this response over time suggests that decreased DEX-CRH responses in this group may be a trait rather than a state marker. This finding is compatible with a hypothesis that HPA axis hyporeactivity may reflect a preexisting vulnerability in these subjects.
BACKGROUND: We recently reported marked hyporeactivity of the hypothalamo-pituitary-adrenal (HPA) axis in depressed women on job-stress-related long-term sick leave (LTSL). This unexpected finding prompted the question of whether HPA axis hypofunction in this group results from stress exposure or reflects preexisting vulnerability. Here, as a first step toward addressing this question, we assessed temporal stability of HPA axis reactivity in these subjects. METHOD: We used the combined dexamethasone/corticotropin-releasing hormone (DEX-CRH) test to retest HPA axis reactivity in 29 patients and 27 control subjects after 12 months of follow-up. Clinical status and cognitive performance was also retested. RESULTS: Despite marked clinical improvement and normalization of initially observed impairments in attention and working memory, marked HPA axis hyporeactivity persisted in patients. A high test-retest correlation was found both at the level of corticotropin (R = .85, p < .001) and cortisol (R = .76, p < .001) responses. CONCLUSIONS: Hyporeactivity of the HPA was stable over 12 months in LTSL subjects, independent of clinical improvement and normalized cognitive function. The stability of this response over time suggests that decreased DEX-CRH responses in this group may be a trait rather than a state marker. This finding is compatible with a hypothesis that HPA axis hyporeactivity may reflect a preexisting vulnerability in these subjects.
Authors: A Oshima; S Yamashita; T Owashi; T Murata; C Tadokoro; H Miyaoka; K Kamijima; T Higuchi Journal: J Psychiatr Res Date: 2000 Jul-Oct Impact factor: 4.791
Authors: Mark W Gilbertson; Martha E Shenton; Aleksandra Ciszewski; Kiyoto Kasai; Natasha B Lasko; Scott P Orr; Roger K Pitman Journal: Nat Neurosci Date: 2002-11 Impact factor: 24.884
Authors: Thomas Johansen; Irene Øyeflaten; Hege R Eriksen; Peter S Lyby; Winand H Dittrich; Inge Holsen; Hanne Jakobsen; Ruby Del Risco Kollerud; Chris Jensen Journal: J Occup Rehabil Date: 2021-01-20
Authors: D Lindqvist; J Fernström; C Grudet; L Ljunggren; L Träskman-Bendz; L Ohlsson; Å Westrin Journal: Transl Psychiatry Date: 2016-12-06 Impact factor: 6.222
Authors: Johanna Wallensten; Marie Åsberg; Åke Nygren; Robert Szulkin; Håkan Wallén; Fariborz Mobarrez; Anna Nager Journal: PLoS One Date: 2016-05-04 Impact factor: 3.240
Authors: Markus Paananen; Peter O'Sullivan; Leon Straker; Darren Beales; Pieter Coenen; Jaro Karppinen; Craig Pennell; Anne Smith Journal: Arthritis Res Ther Date: 2015-12-10 Impact factor: 5.156